The World Health Organisation, WHO has warned patients with mild or moderate cases of COVID-19, against the use of fluvoxamine, an antidepressant drug, and colchicine, a drug for gout.

The WHO said current indications did not justify using colchicine to treat non-severe illnesses, and that fluvoxamine should not be used without clinical trials.

The report by the WHO Guideline Development Group said the advice became necessary due to insufficient evidence of better results from the use of the drugs and their potential harm. a panel of international experts in the British Medical Journal.

Source: Vanguard